Detalhe da pesquisa
1.
Poly-ICLC, a multi-functional immune modulator for treating cancer.
Semin Immunol
; 49: 101414, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33011064
2.
A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy.
Cancer Sci
; 112(7): 2705-2713, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-34009705
3.
Interruption of MDM2 signaling augments MDM2-targeted T cell-based antitumor immunotherapy through antigen-presenting machinery.
Cancer Immunol Immunother
; 70(12): 3421-3434, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33866408
4.
Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw.
FASEB J
; 34(2): 2595-2608, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31919918
5.
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice.
Cancer Immunol Immunother
; 68(3): 455-466, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30604041
6.
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
J Transl Med
; 17(1): 207, 2019 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31221178
7.
Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy.
Hepatology
; 68(2): 574-589, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29443377
8.
Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice.
Cancer Immunol Immunother
; 67(7): 1091-1103, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29696308
9.
Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2-4, 2016.
Cancer Immunol Immunother
; 66(9): 1243-1247, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28484800
10.
Designing therapeutic cancer vaccines by mimicking viral infections.
Cancer Immunol Immunother
; 66(2): 203-213, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27052572
11.
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Cancer Immunol Immunother
; 66(6): 705-716, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28243692
12.
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.
Cancer Immunol Immunother
; 66(7): 877-890, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28349165
13.
Oxidized lipids block antigen cross-presentation by dendritic cells in cancer.
J Immunol
; 192(6): 2920-31, 2014 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24554775
14.
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents.
Mol Ther
; 23(5): 845-856, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25544599
15.
NF-κB is crucial in proximal T-cell signaling for calcium influx and NFAT activation.
Eur J Immunol
; 44(12): 3741-6, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25251667
16.
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.
Cancer Immunol Immunother
; 64(8): 1057-66, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25986168
17.
CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Cancer Immunol Immunother
; 64(6): 697-705, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25754123
18.
Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.
J Immunol
; 190(4): 1873-81, 2013 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23315072
19.
Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53.
Cancer Immunol Immunother
; 63(5): 469-78, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24633296
20.
Tumor-derived TGF-ß and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor.
J Transl Med
; 12: 265, 2014 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25240937